Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization ; volume:21 ; number:1 ; day:17 ; month:5 ; year:2021 ; pages:1-10 ; date:12.2021
Cancer cell international ; 21, Heft 1 (17.5.2021), 1-10, 12.2021
- Creator
-
Sajjadi, Elham
Venetis, Konstantinos
Piciotti, Roberto
Invernizzi, Marco
Guerini-Rocco, Elena
Haricharan, Svasti
Fusco, Nicola
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-01976-y
- URN
-
urn:nbn:de:101:1-2021091623040422176869
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sajjadi, Elham
- Venetis, Konstantinos
- Piciotti, Roberto
- Invernizzi, Marco
- Guerini-Rocco, Elena
- Haricharan, Svasti
- Fusco, Nicola
- SpringerLink (Online service)
Other Objects (12)
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
The biology and molecular vulnerabilities of ATM-deficient cancers
Testing for deficient mismatch repair and microsatellite instability : A focused update
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Evaluation of human and murine frameshift peptide neoantigens for the development of a preventive vaccine against Lynch syndrome-associated mismatch repair deficient cancers
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
The biology and molecular vulnerabilities of ATM-deficient cancers
Testing for deficient mismatch repair and microsatellite instability : A focused update
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Evaluation of human and murine frameshift peptide neoantigens for the development of a preventive vaccine against Lynch syndrome-associated mismatch repair deficient cancers
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
The biology and molecular vulnerabilities of ATM-deficient cancers
Testing for deficient mismatch repair and microsatellite instability : A focused update
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Evaluation of human and murine frameshift peptide neoantigens for the development of a preventive vaccine against Lynch syndrome-associated mismatch repair deficient cancers